Panagora Asset Management Inc Reata Pharmaceuticals Inc Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$100.0 - $143.02 $96,400 - $137,871	-964 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$94.25 - $132.81 $90,857 - $128,028	964 New	964 $96,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $76.44 $606,720 - $951,142	-12,443 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$35.64 - $92.06 $443,468 - $1.15 Million	12,443 New	12,443 $1.02 Million
Q1 2018 May 15, 2018	SELL	$20.0 - $30.19 $153,860 - $232,251	-7,693 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$22.39 - $33.27 $172,246 - $255,946	7,693	7,693 $218,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.